Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Cranage

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Expert Opinion on Biological Therapy|July 16, 2005
Carriers for the delivery of a vaccine against respiratory syncytial virusMartin Cranage, Geraldine Taylor
Methods in Molecular Biology (Clifton, N.J.)|December 1, 2010
Detection, quantification, and characterisation of HIV/SIVNeil Berry, Carolina Herrera, Martin Cranage
Frontiers in Immunology|November 12, 2020
Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?Alberto Beretta, Martin Cranage, Donato Zipeto
Antimicrobial Agents and Chemotherapy|March 5, 2009
Reverse transcriptase inhibitors as potential colorectal microbicidesCarolina Herrera, Martin Cranage, Ian McGowan, et al.
AIDS (London, England)|August 4, 2011
Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explantsCarolina Herrera, Martin Cranage, Ian McGowan, et al.
Virology|March 12, 2002
Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responsesSally Sharpe, Anthony Fooks, John Lee, et al.
Plos One|February 20, 2014
Complement-mediated virus infectivity neutralisation by HLA antibodies is associated with sterilising immunity to SIV challenge in the macaque model for HIV/AIDSMark Page, Ruby Quartey-Papafio, Mark Robinson, et al.
Virology|September 3, 2003
Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus AnkaraSally Sharpe, Tomás Hanke, Anne Tinsley-Bown, et al.
The Journal of General Virology|August 22, 2001
Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunitySally Sharpe, Natasha Polyanskaya, Mike Dennis, et al.
Vaccine|September 15, 2009
Vaginal delivery of the recombinant HIV-1 clade-C trimeric gp140 envelope protein CN54gp140 within novel rheologically structured vehicles elicits specific immune responsesRhonda M Curran, Louise Donnelly, Ryan J Morrow, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|July 16, 2005
Carriers for the delivery of a vaccine against respiratory syncytial virusMartin Cranage, Geraldine Taylor
Methods in Molecular Biology (Clifton, N.J.)|December 1, 2010
Detection, quantification, and characterisation of HIV/SIVNeil Berry, Carolina Herrera, Martin Cranage
Frontiers in Immunology|November 12, 2020
Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?Alberto Beretta, Martin Cranage, Donato Zipeto
Antimicrobial Agents and Chemotherapy|March 5, 2009
Reverse transcriptase inhibitors as potential colorectal microbicidesCarolina Herrera, Martin Cranage, Ian McGowan, et al.
AIDS (London, England)|August 4, 2011
Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explantsCarolina Herrera, Martin Cranage, Ian McGowan, et al.
Virology|March 12, 2002
Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responsesSally Sharpe, Anthony Fooks, John Lee, et al.
Plos One|February 20, 2014
Complement-mediated virus infectivity neutralisation by HLA antibodies is associated with sterilising immunity to SIV challenge in the macaque model for HIV/AIDSMark Page, Ruby Quartey-Papafio, Mark Robinson, et al.
Virology|September 3, 2003
Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus AnkaraSally Sharpe, Tomás Hanke, Anne Tinsley-Bown, et al.
The Journal of General Virology|August 22, 2001
Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunitySally Sharpe, Natasha Polyanskaya, Mike Dennis, et al.
Vaccine|September 15, 2009
Vaginal delivery of the recombinant HIV-1 clade-C trimeric gp140 envelope protein CN54gp140 within novel rheologically structured vehicles elicits specific immune responsesRhonda M Curran, Louise Donnelly, Ryan J Morrow, et al.
Pageof 2